A vaccine formulated with a combination of TLR-2 and TLR-9 adjuvants and the recombinant major outer membrane protein elicits a robust immune response and significant protection against a Chlamydia muridarum challenge

Published 2013 View Full Article

Authors

Keywords

Journal

MICROBES AND INFECTION

Volume 16, Issue 3, Pages 244-252

Publisher

Elsevier BV

Online

2013-11-27

DOI

10.1016/j.micinf.2013.11.009

Ask authors/readers for more resources

Become a Peeref-certified reviewer

The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.

Get Started

Ask a Question. Answer a Question.

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started

MICROBES AND INFECTION

Ask authors/readers for more resources

Protocol

Reagent

Reprint

Become a Peeref-certified reviewer

Ask a Question. Answer a Question.